0
0
Hyderabad, India — Approximately 25% of India’s population suffers from varicose veins, a condition marked by swollen, twisted veins often found in the legs, which experts say remains largely underdiagnosed across the country. However, medical specialists are optimistic about advancements in non-surgical treatment options that are transforming vascular care and increasing accessibility for patients nationwide, even in remote areas.
This week, over 100 prominent healthcare professionals gathered for the Indian Vein Congress (IVC) 2024 in Hyderabad, an event organized by Avis Hospitals. It focused on pioneering advancements in non-surgical solutions for vascular diseases. Led by Dr. Rajah V. Koppala, a distinguished vascular interventional specialist and the founder of Avis Hospitals, the event also saw virtual participation from international experts in Brazil, including Dr. Rodrigo Gomes de Oliveira and Dr. Fernando Tres Silveira, who provided insights into global trends and emerging challenges in vascular and interventional radiology.
The Congress highlighted that non-surgical treatments, such as laser therapy and endovascular procedures, are becoming increasingly effective in managing varicose veins, offering painless, day-care solutions that have made significant impacts on patient outcomes. Dr. Koppala shared that Avis Hospitals has successfully treated over 40,000 patients using these innovative methods over the past eight years, emphasizing the importance of continuous learning and adaptation to new developments.
“While non-surgical treatments have revolutionized patient care, it is crucial to recognize cases where surgery remains the best option. The expertise shared here will benefit practitioners across the country, helping them make informed decisions for complex cases,” Dr. Koppala stated. He added that the Congress is “not just about sharing information but about shaping the future of medical practice in India.”
Dr. Roy Varghese, a vascular surgeon who attended the event, noted that chronic venous disease affects an estimated 20-35% of India’s adult population. He commended the effectiveness of endovascular procedures, which have made treatment more accessible and less invasive, allowing many patients to avoid prolonged recovery times.
Medical technology companies like Medtronic also showcased cutting-edge equipment at the Congress, reflecting the synergy between technological advancements and healthcare practices. Experts at the event stressed that partnerships with technology firms are essential to the ongoing development of vascular treatments and play a pivotal role in providing minimally invasive options for patients.
In a country where varicose veins are often undiagnosed, the IVC 2024 underscored the need for raising awareness and making innovative treatment options accessible. With a commitment to ongoing professional development and adaptation to new, non-surgical techniques, India’s healthcare professionals are well-positioned to improve outcomes for the millions affected by venous disorders.
